| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences Inc. is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for serious and life-threatening diseases. The company’s core franchise centers on therapies for HIV and viral h..
>Volltext.. |
| 139469.38 Mio. EUR |
| 150079.45 Mio. EUR |
| 26164.79 Mio. EUR |
| 12972.59 Mio. EUR |
| 8095.57 Mio. EUR |
| 6.51 EUR |
| 19478.22 Mio. EUR |
| 6700.63 Mio. EUR |
| 9492.27 Mio. EUR |
| 1.04 |
| -2.78% |
| 44.67% |
| 2.77 EUR |
| 2.58% |
| 2.59% |
| 15.06.26 - 0.707578€ 13.03.26 - 0.714384€ >weitere anzeigen... |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.389.151 Euro. |
| GILEAD, REMDESIVIR |
| 28.06.26 |